- Home
- BST vs CERT Comparison
BST vs CERT Comparison
Compare BST & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BST
- CERT
- Stock Information
- Founded
- BST 2014
- CERT 2008
- Country
- BST United States
- CERT United States
- Employees
- BST N/A
- CERT N/A
- Industry
- BST Finance Companies
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- BST Finance
- CERT Technology
- Exchange
- BST Nasdaq
- CERT Nasdaq
- Market Cap
- BST 1.3B
- CERT 1.5B
- IPO Year
- BST N/A
- CERT 2020
- Fundamental
- Price
- BST $39.28
- CERT $11.02
- Analyst Decision
- BST
- CERT Buy
- Analyst Count
- BST 0
- CERT 7
- Target Price
- BST N/A
- CERT $15.00
- AVG Volume (30 Days)
- BST 94.9K
- CERT 1.5M
- Earning Date
- BST 01-01-0001
- CERT 08-06-2025
- Dividend Yield
- BST 7.55%
- CERT N/A
- EPS Growth
- BST N/A
- CERT N/A
- EPS
- BST N/A
- CERT 0.05
- Revenue
- BST N/A
- CERT $405,755,000.00
- Revenue This Year
- BST N/A
- CERT $11.52
- Revenue Next Year
- BST N/A
- CERT $8.74
- P/E Ratio
- BST N/A
- CERT $222.12
- Revenue Growth
- BST N/A
- CERT 11.61
- 52 Week Low
- BST $27.87
- CERT $8.64
- 52 Week High
- BST $40.21
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- BST 55.90
- CERT 53.63
- Support Level
- BST $39.42
- CERT $10.38
- Resistance Level
- BST $40.21
- CERT $11.26
- Average True Range (ATR)
- BST 0.42
- CERT 0.51
- MACD
- BST -0.01
- CERT 0.12
- Stochastic Oscillator
- BST 51.31
- CERT 73.61
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.